| | Methods | Matrices | Compounds | Linear range | Recovery (%) | LOD | Ref |
| | HF-LPME-UV | Bovine milk, human plasma, and water | 3 TC | 0.5-1000 μg·L−1 | Not reported | 0.5-1.0 μg·L−1 | [10] | | HF-SLM-MS | Urine, milk, and bovine liver | 16 SAs | NR | >90% | 3.3-10.0 (liver) μg·kg−1, 2.5-15.0 (urine) μg·L−1, 12.4-24.3 (milk) μg·L−1 | [16] | | HF-LPME-UV | Environmental water | 5 SAs | 1-2000 ng·L−1 | 82.2–103.2 | 0.1-0.4 μg·L−1 | [19] | | HF-LPME-GC | Sausage, corned meat, fresh meat, and salted eggs | 2 carcinogenic nitrosamines | 5000-25000 μg·kg−1 | 100.0 and 1010 | 330.0 and 20.0 μg·L−1 | [25] | | HF-LPME-DAD/FL | Bovine urine and water | 8 FQ | 0.02-1 000 μg·L−1 | 76.0–100.5 | 0.0003-0.016 μg·L−1 | [26] | | VA–HF–LPME-DAD | Eggs | 2 carotenoids | 50-1000 μg·kg−1 | 90.8–101.8 | 0.038 and 0.045 μg·kg−1 | [27] | | HF-LPME-DAD/FLD | Human urine | 3 nonsteroidal anti-inflammatory drugs | 41-10000 μg·L−1 | 82.3–99.0 | 12.53-40.00 μg·kg−1 | [28] | | SPE-LC-MS/MS | Eggs | 10 SAs | NR | 99.8–100.4 | <20.5 (CC ) | [29] | | SPE-UHPLC-MS/MS | Eggs | 8 As, 4 TC, 5 Qs, 4 SAs, 4 Macs | 5-100 μg·kg−1 | 54.0-76.0 (SAs) | NR | [30] | | QuEChERS- UHPLC-MS/MS | Eggs | 8 As, 4 TC, 5 Qs, 4 SAs, 4 Macs | 5-100 μg·kg−1 | 56.0-76.0 (SAs) | NR | [30] | | MSPD- UHPLC-MS/MS | Eggs | 8 As, 4 TC, 5 Qs, 4 SAs, 4 Macs | 5-100 μg·kg−1 | 62.0-89.0 (SAs) | NR | [30] | | SE-UHPLC-MS/MS | Eggs | 8 As, 4 TC, 5 Qs, 4 SAs, 4 Macs | 5-100 μg·kg−1 | 73.0-89.0 (SAs) | 6.1-114.2 (CC ) SA | [31] | | LLE-SPE-HPLC-MS/MS | Eggs | 10 SAs | NR | 91.0–146.0 | 7.4–26.0 (CC ) | [31] | | HF-SLM-DAD | Eggs | 15 SAs | 5-1000 μg·kg−1 | 71.0–98.7 | 0.8-7.9 μg·kg−1 | Proposed method |
|
|
